• Search here
Get Quotes

Get Quotes

Dr. Kapil Kumar

Dr. Kapil Kumar
Education : MBBS MS
Experience : 25 Years
Awards : 6
Specility Interest : Breast cancer and oncoplastic surgery, Upper G.I.Onco surgery, Pancreatic Biliary surgery
Designation : Director - BLKCC & HOD - Surgical Oncology
Department : Oncology
Hospital : BLK Super Speciality Hospital New Delhi

Get Opinion

About

Dr. Kapil Kumar is presently working as a Director- BLKCC & HOD- Surgical Oncology at BLK Super Speciality Hospital, New Delhi Previous Experience: Senior Consultant - Rajiv Gandhi Cancer Inst. & Research Centre, Rohini, Delhi Consultant - Oswal Cancer Hospital, Ludhiana, Punjab Senior Consultant - Batra Hospital and Medical Research Centre, New Delhi Honorary Senior Consultant - Dharamshila Cancer Hospital, New Delhi

Qualification

  • MBBS
  • MS (Surgery)

Experience

Presently working as a Director- BLKCC & HOD- Surgical Oncology at BLK Super Speciality Hospital, New Delhi

Previous Experience:

  • Senior Consultant - Rajiv Gandhi Cancer Inst. & Research Centre, Rohini, Delhi
  • Consultant - Oswal Cancer Hospital, Ludhiana, Punjab
  • Senior Consultant - Batra Hospital and Medical Research Centre, New Delhi
  • Honorary Senior Consultant - Dharamshila Cancer Hospital, New Delhi

Speciality Interest

Breast cancer and oncoplastic surgery, Upper G.I.Onco surgery, Pancreatic Biliary surgery, Thoracic surgery including Esophagus cancer, Lung cancers & Mediastinal tumors.

Awards and Achievements

Dhanvantari award from Cholay1 Foundation for Onco- Surgery work

Membership

  • Life Member, Indian Society of Oncology (I.S.O.)
  • International Society of Diseases of Esophagus (I.S.D.E.)
  • Life Member, Delhi Medical Association (D.M.A.)

Publication:

  • Peritoneal Echinococcus Multi Loculari's Infection: CT appearance J, Comput, Assist,Tomogr, Vol.14, No.-3, 1990.
  • Surgical Oncology in the third millennium: Why Sacrifice more when less will do - Journal of Safdarjang Hospital, Volume VII Jan. 2000, 31-34.
  • Changing concepts in Breast Cancer - Chandigarh Medical Journal - September 2002.
  • MRI- guided biopsy- Our preliminary experience. Indian J Radiol Imaging - August 2010.
  • Kras Gene Mutation and RASSF1A, FHIT & MGMT Gene Promoter Hypermethylation Indicators of Tumor Staging and Metastasis in Adenocarcinomatous Sporadic Colorectal Cancer in Indian Population.- April 2013
  • P16(INK4a) promoter methylation and expression in sporadic breast cancer. -Journal of Carcinogenesis-Sep.2012
  • MGMT & RASSF1A Gene promoter hypermethylation in sporadic colorectal cancer in Indian population. - Journal of Carcinogenesis-Sep.2012

 


Write Review